Andreas Kjær

Andreas Kjær

Professor


  1. Published

    Development of the First Aliphatic 18F-Labeled Tetrazine Suitable for Pretargeted PET Imaging-Expanding the Bioorthogonal Tool Box

    Battisti, Umberto Maria, Bratteby, K., Jørgensen, Jesper Tranekjær, Hvass, Lars, Shalgunov, Vladimir, Mikula, H., Kjær, Andreas & Herth, Matthias Manfred, 2021, In: Journal of Medicinal Chemistry. 64, 20, p. 15297–15312

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Published

    Direct Cu-mediated aromatic18F-labeling of highly reactive tetrazines for pretargeted bioorthogonal PET imaging

    García-Vázquez, R., Battisti, Umberto Maria, Jørgensen, Jesper Tranekjær, Shalgunov, Vladimir, Hvass, Lars, Stares, D. L., Petersen, I. N., Crestey, F., Löffler, A., Svatunek, D., Kristensen, Jesper Langgaard, Mikula, H., Kjær, Andreas & Herth, Matthias Manfred, 2021, In: Chemical Science. 12, 35, p. 11668-11675

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    EARLY MYOCARDIAL TISSUE RESPONSE TO ADIPOSE TISSUE-DERIVED STROMAL CELL THERAPY IN A RAT MODEL OF CHRONIC MYOCARDIAL INFARCTION

    Follin, Bjarke, Hoeeg, C., Højgaard, Liselotte, Lund, K. B., Juhl, M., Døssing, Kristina Benedikte V, Ringgaard, L., Grandjean, C., Ripa, Rasmus Sejersten, Ekblond, A., Kjær, Andreas & Kastrup, J., 2021, In: Cytotherapy. 23, 5, p. S52-S52 1 p., 140.

    Research output: Contribution to journalConference abstract in journalResearch

  4. Published

    Effect of 26 Weeks of Liraglutide Treatment on Coronary Artery Inflammation in Type 2 Diabetes Quantified by [64Cu]Cu-DOTATATE PET/CT: Results from the LIRAFLAME Trial

    Jensen, Jacob Kildevang, Zobel, E. H., von Scholten, B. J., Rotbain Curovic, V., Hansen, T. W., Rossing, Peter, Kjær, Andreas & Ripa, Rasmus Sejersten, 2021, In: Frontiers in Endocrinology. 12, 10 p., 790405.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Effect of Liraglutide on Arterial Inflammation Assessed as [F-18]FDG Uptake in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial

    Ripa, Rasmus Sejersten, Zobel, E. H., von Scholten, B. J., Jensen, Jacob Kildevang, Binderup, Tina, Diaz, L. J., Curovic, V. R., Hansen, T. W., Rossing, Peter & Kjær, Andreas, 2021, In: Circulation: Cardiovascular Imaging. 14, 7, 13 p., 012174.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Effect of apoA-I PEGylation on the Biological Fate of Biomimetic High-Density Lipoproteins

    Pedersbæk, D., Krogager, L., Albertsen, Camilla Hald, Ringgaard, L., Hansen, A. E., Jønsson, K., Larsen, J. B., Kjær, Andreas, Andresen, T. L. & Simonsen, J. B., 2021, In: ACS Omega. 6, 1, p. 871-880

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Effect of liraglutide on expression of inflammatory genes in type 2 diabetes

    Zobel, E. H., Ripa, Rasmus Sejersten, von Scholten, B. J., Rotbain Curovic, V., Kjær, Andreas, Hansen, T. W., Rossing, Peter & Størling, Joachim, 2021, In: Scientific Reports. 11, 18522.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Effect of liraglutide on vascular inflammation evaluated by [64 cu]dotatate

    Zobel, E. H., Ripa, Rasmus Sejersten, von Scholten, B. J., Curovic, V. R., Diaz, L. J., Hansen, T. W., Rossing, Peter & Kjær, Andreas, 2021, In: Diagnostics. 11, 8, 11 p., 1431.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Effective Intratumoral Retention of [103Pd]AuPd Alloy Nanoparticles Embedded in Gel-Forming Liquids Paves the Way for New Nanobrachytherapy

    Fach, M., Fliedner, F. P., Kempen, P. J., Melander, F., Hansen, A. E., Bruun, L. M., Köster, U., Sporer, E., Kjær, Andreas, Andresen, T. L., Jensen, A. I. & Henriksen, J. R., 2021, In: Advanced Healthcare Materials. 10, 10, 11 p., 2002009.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Effects of empagliflozin on myocardial flow reserve in patients with type 2 diabetes mellitus: The simple trial

    Jürgens, M., Schou, Morten, Hasbak, P., Kjær, Andreas, Wolsk, E., Zerahn, B., Wiberg, M., Brandt-Jacobsen, N. H., Gæde, P., Rossing, Peter, Faber, Jens, Inzucchi, S. E., Gustafsson, Finn & Kistorp, Caroline Michaela Nervil, 2021, In: Journal of the American Heart Association. 10, 15, e020418.

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 13402